Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepesh P Lad

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Hematology/Oncology and Stem Cell Therapy|July 6, 2020
Long-term outcomes of innovator versus generic melphalan formulation in autologous hematopoietic cell transplantation for multiple myelomaDeepesh P Lad, Pankaj Malhotra, Amol N Patil, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|April 19, 2021
Efficacy, safety, and quality of life of generic and innovator ibrutinib in Indian CLL patientsCharanpreet Singh, Nishant Jindal, Padma Youron, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|October 29, 2024
Maternal and Foetal Outcomes of Newly Diagnosed Chronic Myeloid Leukemia During Pregnancy and its Long-Term ImpactUrmimala Bhattacharjee, Charanpreet Singh, Aditya Jandial, et al.
Leukemia Research|August 11, 2023
Pregnancy and long-term outcomes of female patients with chronic myeloid leukemia on tyrosine kinase inhibitors who experienced unplanned pregnanciesUrmimala Bhattacharjee, Aditya Jandial, Charanpreet Singh, et al.
Transplantation and Cellular Therapy|May 16, 2023
Randomized Controlled Trial of Isha Kriya versus Observation to Improve Quality of Life in Hematopoietic Cell Transplantation RecipientsMadhu Chopra, R Rambabu Naik, Roseline Naik, et al.
Blood Cell Therapy|June 22, 2023
Role of fluoroquinolone prophylaxis in allogeneic hematopoietic cell transplantation in regions with a high prevalence of fluoroquinolone resistanceAshwin Nair, Shaweta Kaundal, Kripa Shanker Kasudhan, et al.
Blood Cell Therapy|January 30, 2023
Adherence to long-term follow-up preventive practices in allogeneic hematopoietic cell transplantation survivors from North IndiaNiranjan S Khaire, Prashant Chhabra, Dikshat G Gupta, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 25, 2021
Impact of broad-spectrum antibiotic exposures and multidrug-resistant gram-negative bacteremia on hematopoietic cell transplantation outcomesShaweta Kaundal, Aditya Jandial, Harmandeep Singh, et al.
Annals of Hematology|April 18, 2024
Pharmacogenetic guided versus standard warfarin dosing for routine clinical care with its pharmacoeconomic impact: a randomized controlled clinical trialAishwarya Anand, Naveen C Hegde, Pulkit Chhabra, et al.
Leukemia & Lymphoma|June 14, 2022
Post-transplant cyclophosphamide pharmacokinetics and haploidentical hematopoietic cell transplantation outcomes: an exploratory studyKripa Shanker Kasudhan, Amol N Patil, Aditya Jandial, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Hematology/Oncology and Stem Cell Therapy|July 6, 2020
Long-term outcomes of innovator versus generic melphalan formulation in autologous hematopoietic cell transplantation for multiple myelomaDeepesh P Lad, Pankaj Malhotra, Amol N Patil, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|April 19, 2021
Efficacy, safety, and quality of life of generic and innovator ibrutinib in Indian CLL patientsCharanpreet Singh, Nishant Jindal, Padma Youron, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|October 29, 2024
Maternal and Foetal Outcomes of Newly Diagnosed Chronic Myeloid Leukemia During Pregnancy and its Long-Term ImpactUrmimala Bhattacharjee, Charanpreet Singh, Aditya Jandial, et al.
Leukemia Research|August 11, 2023
Pregnancy and long-term outcomes of female patients with chronic myeloid leukemia on tyrosine kinase inhibitors who experienced unplanned pregnanciesUrmimala Bhattacharjee, Aditya Jandial, Charanpreet Singh, et al.
Transplantation and Cellular Therapy|May 16, 2023
Randomized Controlled Trial of Isha Kriya versus Observation to Improve Quality of Life in Hematopoietic Cell Transplantation RecipientsMadhu Chopra, R Rambabu Naik, Roseline Naik, et al.
Blood Cell Therapy|June 22, 2023
Role of fluoroquinolone prophylaxis in allogeneic hematopoietic cell transplantation in regions with a high prevalence of fluoroquinolone resistanceAshwin Nair, Shaweta Kaundal, Kripa Shanker Kasudhan, et al.
Blood Cell Therapy|January 30, 2023
Adherence to long-term follow-up preventive practices in allogeneic hematopoietic cell transplantation survivors from North IndiaNiranjan S Khaire, Prashant Chhabra, Dikshat G Gupta, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 25, 2021
Impact of broad-spectrum antibiotic exposures and multidrug-resistant gram-negative bacteremia on hematopoietic cell transplantation outcomesShaweta Kaundal, Aditya Jandial, Harmandeep Singh, et al.
Annals of Hematology|April 18, 2024
Pharmacogenetic guided versus standard warfarin dosing for routine clinical care with its pharmacoeconomic impact: a randomized controlled clinical trialAishwarya Anand, Naveen C Hegde, Pulkit Chhabra, et al.
Leukemia & Lymphoma|June 14, 2022
Post-transplant cyclophosphamide pharmacokinetics and haploidentical hematopoietic cell transplantation outcomes: an exploratory studyKripa Shanker Kasudhan, Amol N Patil, Aditya Jandial, et al.
Pageof 4